Literature DB >> 26430488

Randomized, Observer-blind, Split-face Compatibility Study with Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% gel and Facial Foundation Makeup.

Neal Bhatia1, Radhakrishnan Pillai2.   

Abstract

BACKGROUND: Cosmetic compatibility in the treatment of acne is an important issue significantly impacting quality of life, but often overlooked, as dermatologists commonly recommended avoidance of cosmetic foundations when treating adult female patients. Fixed combinations of clindamycin/benzoyl peroxide are widely used in the treatment of acne, but little is known about the impact of their concomitant use with facial foundation.
OBJECTIVE: To assess the compatibility of clindamycin phosphate 1. 2%/benzoyl peroxide 3. 75% gel with foundation makeup for up to six hours after application.
METHODS: Twenty-nine female subjects applied makeup to their face after randomly applying clindamycin phosphate 1. 2%/benzoyl peroxide 3. 75% gel to one side of the face. Investigator and subject self- assessment included facial skin attributes, facial tolerability, and cosmetic compatibility post-application and at Hour 6; as well as cutaneous tolerability.
RESULTS: No statistical difference was noted between the treated and untreated side of the face in terms of coverage, blotchiness, appearance, skin tone, or visual smoothness. Tolerability was excellent, with no erythema, edema, dryness, and peeling post-makeup application. For both the treated and untreated side, there was a slight lack of improvement in cosmetic appearance six hours post-makeup application.
CONCLUSION: Clindamycin/benzoyl peroxide 3. 75% gel was shown to have excellent cosmetic compatibility with facial foundation.

Entities:  

Year:  2015        PMID: 26430488      PMCID: PMC4587892     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  11 in total

1.  A photonumeric scale for the assessment of cutaneous photodamage.

Authors:  C E Griffiths; T S Wang; T A Hamilton; J J Voorhees; C N Ellis
Journal:  Arch Dermatol       Date:  1992-03

2.  Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris.

Authors:  Yoshie Matsuoka; Kozo Yoneda; Chieko Sadahira; Junko Katsuura; Tetsuya Moriue; Yasuo Kubota
Journal:  J Dermatol       Date:  2006-11       Impact factor: 4.005

Review 3.  New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group.

Authors:  Diane Thiboutot; Harald Gollnick; Vincenzo Bettoli; Brigitte Dréno; Sewon Kang; James J Leyden; Alan R Shalita; Vicente Torres Lozada; Diane Berson; Andrew Finlay; Chee Leok Goh; María Isabel Herane; Ana Kaminsky; Raj Kubba; Alison Layton; Yoshiki Miyachi; Montserrat Perez; Jaime Piquero Martin; Marcia Ramos-E-Silva; Jo Ann See; Neil Shear; John Wolf
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

Review 4.  Clinical considerations on the use of concomitant therapy in the treatment of acne.

Authors:  Andrew F Alexis
Journal:  J Dermatolog Treat       Date:  2008       Impact factor: 3.359

5.  Why and when the treatment of acne fails. What to do.

Authors:  A D Katsambas
Journal:  Dermatology       Date:  1998       Impact factor: 5.366

6.  Make-up improves the quality of life of acne patients without aggravating acne eruptions during treatments.

Authors:  Nobukazu Hayashi; Mizuho Imori; Midori Yanagisawa; Yoko Seto; Osamu Nagata; Makoto Kawashima
Journal:  Eur J Dermatol       Date:  2005 Jul-Aug       Impact factor: 3.328

Review 7.  Fixed-combination products in the management of acne vulgaris.

Authors:  Linda Stein Gold
Journal:  Cutis       Date:  2010-03

Review 8.  A review of the use of combination therapies for the treatment of acne vulgaris.

Authors:  James J Leyden
Journal:  J Am Acad Dermatol       Date:  2003-09       Impact factor: 11.527

9.  An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris.

Authors:  David M Pariser; Phoebe Rich; Fran E Cook-Bolden; Andrew Korotzer
Journal:  J Drugs Dermatol       Date:  2014-09       Impact factor: 2.114

10.  Emotional benefit of cosmetic camouflage in the treatment of facial skin conditions: personal experience and review.

Authors:  Lauren L Levy; Jason J Emer
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-11-01
View more
  5 in total

Review 1.  Emerging Issues in Adult Female Acne.

Authors:  Joshua A Zeichner; Hillary E Baldwin; Fran E Cook-Bolden; Lawrence F Eichenfield; Sheila Fallon-Friedlander; David A Rodriguez
Journal:  J Clin Aesthet Dermatol       Date:  2017-01-01

2.  A Split-face, Controlled Study to Assess the Compatibility of Tretinoin 0.05% Acne Lotion with Facial Foundation Makeup.

Authors:  Neal Bhatia; Leon H Kircik; Ava Shamban; Varsha Bhatt; Radhakrishnan Pillai; Eric Guenin
Journal:  J Clin Aesthet Dermatol       Date:  2020-10-01

3.  Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris.

Authors:  Michael H Gold; Andrew Korotzer
Journal:  J Clin Aesthet Dermatol       Date:  2015-12

4.  Topical benzoyl peroxide for acne.

Authors:  Zhirong Yang; Yuan Zhang; Elvira Lazic Mosler; Jing Hu; Hang Li; Yanchang Zhang; Jia Liu; Qian Zhang
Journal:  Cochrane Database Syst Rev       Date:  2020-03-16

5.  Assessment of a new biological complex efficacy on dysseborrhea, inflammation, and Propionibacterium acnes proliferation.

Authors:  Sandra Trompezinski; Sophie Weber; Benoît Cadars; Florence Larue; Nathalie Ardiet; Marlène Chavagnac-Bonneville; Michèle Sayag; Eric Jourdan
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.